Clinical trial
Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
NCT00235872 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00235872 |
|---|---|
| Title | Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis |
| Official title | Open-Label Continuous Administration Study With Adalimumab (D2E7) in Subjects With Rheumatoid Arthritis |
| Lead sponsor | Abbott, Industry |
| Collaborators | Abbott Japan Co.,Ltd Industry Eisai Co., Ltd. |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Biological |
| Interventions | adalimumab |
| Enrollment | 309 |
| Start date | Aug 1, 2004 |
| Primary completion | Jul 1, 2006 |
| First posted | Oct 12, 2005 |
| Last update posted | Apr 11, 2011 |
| Countries | Japan |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: